From groundbreaking findings from the UK Medical Cannabis Registry to clinical trials by the industry’s leading experts, explore the latest advancements in medical cannabis research.
Medical cannabis prescriptions have been on the rise in the UK since a 2018 law change allowed specialist ...
Since medical cannabis was legalised in the UK on the 1st of November 2018, three cannabis-based medicinal products ...
While medical cannabis products are increasingly prescribed for patients with chronic health conditions in the UK and internationally, ...
Autism spectrum disorder (autism) is a neurodevelopmental condition, caused by differences in the brain and characterised by differences ...
Cannabis Sativa is a complex plant containing hundreds of active components, including cannabinoids, terpenes, flavonoids and more. Medical ...
On 25th June 2018, the US Food and Drug Administration (FDA) approved Epidiolex, a cannabidiol (CBD)-based prescription medication, ...
Back pain is the leading cause of years lived with disability in industrialised countries, with the annual prevalence ...
Osteoarthritis (OA) is the most common of arthritic conditions. It is estimated to affect around 10 million people ...
In recent years, interest in the therapeutic potential of cannabidiol (CBD) has skyrocketed. The cannabinoid has been investigated ...
Poor sleep is associated with several health problems, including hypertension, diabetes, obesity, depression, heart attack, and stroke. Sleep ...
Inflammatory Bowel Disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC) are conditions that are characterised by ...
Attention-deficit hyperactivity disorder (ADHD) is a behavioural condition characterised by impairing levels of inattention, hyperactivity, or impulsivity – ...
